Accessibility Menu
 
Trinity Biotech Plc logo

Trinity Biotech Plc

(NASDAQ) TRIB

Current Price$0.60
Market Cap$11.45M
Since IPO (1992)-99%
5 Year-96%
1 Year-23%
1 Month-2%

Trinity Biotech Plc Financials at a Glance

Market Cap

$11.45M

Revenue (TTM)

$43.86M

Net Income (TTM)

$37.42M

EPS (TTM)

$-2.02

P/E Ratio

-0.29

Dividend

$0.00

Beta (Volatility)

0.60 (Low)

Price

$0.60

Volume

300

Open

$0.61

Previous Close

$0.59

Daily Range

$0.60 - $0.62

52-Week Range

$0.50 - $3.44

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Trinity Biotech Plc

Industry

Healthcare Equipment and Supplies

Employees

287

CEO

John Gillard

Headquarters

Bray, A98 H5C8, IE

TRIB Financials

Key Financial Metrics (TTM)

Gross Margin

35%

Operating Margin

-26%

Net Income Margin

-85%

Return on Equity

0%

Return on Capital

31%

Return on Assets

-36%

Earnings Yield

-3.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.45M

Shares Outstanding

19.34M

Volume

300

Avg. Volume

173.31K

Financials (TTM)

Gross Profit

$15.55M

Operating Income

$10.96M

EBITDA

$8.26M

Operating Cash Flow

$6.26M

Capital Expenditure

$88.27K

Free Cash Flow

$6.34M

Cash & ST Invst.

$5.14M

Total Debt

$137.98M

Trinity Biotech Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$11.06M

-30.2%

Gross Profit

$3.55M

-27.3%

Gross Margin

32.05%

N/A

Market Cap

$11.45M

N/A

Market Cap/Employee

$30.13K

N/A

Employees

380

N/A

Net Income

$17.46M

-3.0%

EBITDA

$2.21M

+76.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$132.84M

-39.0%

Accounts Receivable

$10.28M

-29.6%

Inventory

$18.83M

-2.8%

Long Term Debt

$27.17M

-72.4%

Short Term Debt

$110.81M

+4341.4%

Return on Assets

-35.58%

N/A

Return on Invested Capital

31.22%

N/A

Free Cash Flow

$1.54M

-350.6%

Operating Cash Flow

$1.55M

-146.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CHEKCheck-Cap Ltd.
$1.68-11.11%
ADVBAdvanced Biomed Inc. Common Stock
$6.69-7.08%
MRKRMarker Therapeutics, Inc.
$1.46+1.39%
SINTSintx Technologies, Inc.
$2.50+4.60%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.45+0.07%
RXTRackspace Technology
$5.02+0.43%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$43.59-0.05%
EOSEEos Energy Enterprises
$7.59+0.19%

Questions About TRIB

What is the current price of Trinity Biotech Plc?

Trinity Biotech Plc is trading at $0.60 per share.

What is the 52-week range for Trinity Biotech Plc?

Over the past 52 weeks, Trinity Biotech Plc has traded between $0.50 and $3.44.

How much debt does Trinity Biotech Plc have?

As of the most recent reporting period, Trinity Biotech Plc reported total debt of $137.98M.

How much cash does Trinity Biotech Plc have on hand?

Trinity Biotech Plc reported $5.14M in cash and cash equivalents in its most recent financial results.

What is Trinity Biotech Plc’s dividend yield?

Trinity Biotech Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.